West Pharmaceutical Services, Inc. (NYSE: WST) reported Q2 EPS of $0.52, $0.05 better than the analyst estimate of $0.47. Revenue for the quarter came in at $368.9 million versus the consensus estimate of $368.6 million.

West Pharmaceutical Services, Inc. reaffirmed FY2014 guidance.

For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.